CHEK1 and breast carcinoma: Growth inhibition of induced EMT HMLE cells and sensitive breast cancer cell lines by CHK1 inhibitors was associated with formation of p-H2A.X and p-53BP1 DNA damage response foci and pan-nuclear staining, and with enrichment for cells in S-phase.